BTIG Reiterates Buy on Medline, Maintains $55 Price Target
Medline Inc MDLN
$39.28
▲ +0.41%
(+$0.16)
📅 Earnings This Week
Open
$39.00
Prev Close
$39.12
Day Range
$38.02 – $39.42
52W Range
$32.82 – $50.88
Market Cap
$51.60B
P/E (TTM)
53.42
Beta
1.16
EPS (TTM)
$1.19
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2025-12-17 |
| Shares Out. | 1,313,690,000 |
| Website | ir.medline.com/ ↗ |
| Phone | 13026365401 |
| Employees | 45,000 |
| Revenue | $7.35B |
| Gross Profit | $1.84B |
| Net Income | $239.0M |
| Total Assets | $39.01B |
| Total Liabilities | $19.67B |
| Equity | $19.35B |
About Medline Inc
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
Medline Inc is a publicly traded company under the ticker symbol MDLN on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
35 analysts (2026-07-01)